Cargando…
Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden
BACKGROUND: Due to the high transmissibility of SARS-CoV-2, accurate diagnosis is essential for effective infection control, but the gold standard, real-time reverse transcriptase-polymerase chain reaction (RT-PCR), is costly, slow, and test capacity has at times been insufficient. We compared the a...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832414/ https://www.ncbi.nlm.nih.gov/pubmed/36631852 http://dx.doi.org/10.1186/s12931-023-02315-7 |
_version_ | 1784868049837359104 |
---|---|
author | Quraishi, Eman Jibuaku, Chiamaka Lisik, Daniil Wennergren, Göran Lötvall, Jan Nyberg, Fredrik Ekerljung, Linda Rådinger, Madeleine Kankaanranta, Hannu Nwaru, Bright I. |
author_facet | Quraishi, Eman Jibuaku, Chiamaka Lisik, Daniil Wennergren, Göran Lötvall, Jan Nyberg, Fredrik Ekerljung, Linda Rådinger, Madeleine Kankaanranta, Hannu Nwaru, Bright I. |
author_sort | Quraishi, Eman |
collection | PubMed |
description | BACKGROUND: Due to the high transmissibility of SARS-CoV-2, accurate diagnosis is essential for effective infection control, but the gold standard, real-time reverse transcriptase-polymerase chain reaction (RT-PCR), is costly, slow, and test capacity has at times been insufficient. We compared the accuracy of clinician diagnosis of COVID-19 against RT-PCR in a general adult population. METHODS: COVID-19 diagnosis data by 30th September 2021 for participants in an ongoing population-based cohort study of adults in Western Sweden were retrieved from registers, based on positive RT-PCR and clinician diagnosis using recommended ICD-10 codes. We calculated accuracy measures of clinician diagnosis using RT-PCR as reference for all subjects and stratified by age, gender, BMI, and comorbidity collected pre-COVID-19. RESULTS: Of 42,621 subjects, 3,936 (9.2%) and 5705 (13.4%) had had COVID-19 identified by RT-PCR and clinician diagnosis, respectively. Sensitivity and specificity of clinician diagnosis against RT-PCR were 78% (95%CI 77–80%) and 93% (95%CI 93–93%), respectively. Positive predictive value (PPV) was 54% (95%CI 53–55%), while negative predictive value (NPV) was 98% (95%CI 98–98%) and Youden’s index 71% (95%CI 70–72%). These estimates were similar between men and women, across age groups, BMI categories, and between patients with and without asthma. However, while specificity, NPV, and Youden’s index were similar between patients with and without chronic obstructive pulmonary disease (COPD), sensitivity was slightly higher in patients with (84% [95%CI 74–90%]) than those without (78% [95%CI 77–79%]) COPD. CONCLUSIONS: The accuracy of clinician diagnosis for COVID-19 is adequate, regardless of gender, age, BMI, and asthma, and thus can be used for screening purposes to supplement RT-PCR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-023-02315-7. |
format | Online Article Text |
id | pubmed-9832414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98324142023-01-11 Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden Quraishi, Eman Jibuaku, Chiamaka Lisik, Daniil Wennergren, Göran Lötvall, Jan Nyberg, Fredrik Ekerljung, Linda Rådinger, Madeleine Kankaanranta, Hannu Nwaru, Bright I. Respir Res Research BACKGROUND: Due to the high transmissibility of SARS-CoV-2, accurate diagnosis is essential for effective infection control, but the gold standard, real-time reverse transcriptase-polymerase chain reaction (RT-PCR), is costly, slow, and test capacity has at times been insufficient. We compared the accuracy of clinician diagnosis of COVID-19 against RT-PCR in a general adult population. METHODS: COVID-19 diagnosis data by 30th September 2021 for participants in an ongoing population-based cohort study of adults in Western Sweden were retrieved from registers, based on positive RT-PCR and clinician diagnosis using recommended ICD-10 codes. We calculated accuracy measures of clinician diagnosis using RT-PCR as reference for all subjects and stratified by age, gender, BMI, and comorbidity collected pre-COVID-19. RESULTS: Of 42,621 subjects, 3,936 (9.2%) and 5705 (13.4%) had had COVID-19 identified by RT-PCR and clinician diagnosis, respectively. Sensitivity and specificity of clinician diagnosis against RT-PCR were 78% (95%CI 77–80%) and 93% (95%CI 93–93%), respectively. Positive predictive value (PPV) was 54% (95%CI 53–55%), while negative predictive value (NPV) was 98% (95%CI 98–98%) and Youden’s index 71% (95%CI 70–72%). These estimates were similar between men and women, across age groups, BMI categories, and between patients with and without asthma. However, while specificity, NPV, and Youden’s index were similar between patients with and without chronic obstructive pulmonary disease (COPD), sensitivity was slightly higher in patients with (84% [95%CI 74–90%]) than those without (78% [95%CI 77–79%]) COPD. CONCLUSIONS: The accuracy of clinician diagnosis for COVID-19 is adequate, regardless of gender, age, BMI, and asthma, and thus can be used for screening purposes to supplement RT-PCR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-023-02315-7. BioMed Central 2023-01-11 2023 /pmc/articles/PMC9832414/ /pubmed/36631852 http://dx.doi.org/10.1186/s12931-023-02315-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Quraishi, Eman Jibuaku, Chiamaka Lisik, Daniil Wennergren, Göran Lötvall, Jan Nyberg, Fredrik Ekerljung, Linda Rådinger, Madeleine Kankaanranta, Hannu Nwaru, Bright I. Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden |
title | Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden |
title_full | Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden |
title_fullStr | Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden |
title_full_unstemmed | Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden |
title_short | Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden |
title_sort | comparison of clinician diagnosis of covid-19 with real time polymerase chain reaction in an adult-representative population in sweden |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832414/ https://www.ncbi.nlm.nih.gov/pubmed/36631852 http://dx.doi.org/10.1186/s12931-023-02315-7 |
work_keys_str_mv | AT quraishieman comparisonofcliniciandiagnosisofcovid19withrealtimepolymerasechainreactioninanadultrepresentativepopulationinsweden AT jibuakuchiamaka comparisonofcliniciandiagnosisofcovid19withrealtimepolymerasechainreactioninanadultrepresentativepopulationinsweden AT lisikdaniil comparisonofcliniciandiagnosisofcovid19withrealtimepolymerasechainreactioninanadultrepresentativepopulationinsweden AT wennergrengoran comparisonofcliniciandiagnosisofcovid19withrealtimepolymerasechainreactioninanadultrepresentativepopulationinsweden AT lotvalljan comparisonofcliniciandiagnosisofcovid19withrealtimepolymerasechainreactioninanadultrepresentativepopulationinsweden AT nybergfredrik comparisonofcliniciandiagnosisofcovid19withrealtimepolymerasechainreactioninanadultrepresentativepopulationinsweden AT ekerljunglinda comparisonofcliniciandiagnosisofcovid19withrealtimepolymerasechainreactioninanadultrepresentativepopulationinsweden AT radingermadeleine comparisonofcliniciandiagnosisofcovid19withrealtimepolymerasechainreactioninanadultrepresentativepopulationinsweden AT kankaanrantahannu comparisonofcliniciandiagnosisofcovid19withrealtimepolymerasechainreactioninanadultrepresentativepopulationinsweden AT nwarubrighti comparisonofcliniciandiagnosisofcovid19withrealtimepolymerasechainreactioninanadultrepresentativepopulationinsweden |